TheraBreath

TheraBreath is an American oral-care brand associated primarily with the management of halitosis, or bad breath. The brand was established in 1994 by Harold Katz, a dentist who began investigating the causes of persistent bad breath after he was unable to resolve the problem affecting his daughter. That experience led him to develop a product-oriented approach centered on the chemical and microbial contributors to oral malodor rather than relying only on masking fragrances. The brand’s formulations are associated with chlorine dioxide, an ingredient used in its oral-care products to help address odor-producing compounds. TheraBreath’s positioning extends beyond temporary breath freshening: its products are marketed for concerns involving the tongue, throat, gum tissue, tonsils, and broader oral freshness. Its portfolio is principally made up of consumer oral-care products such as oral rinses and related breath-care formats, with the brand’s identity strongly tied to dentist-led expertise and bad-breath treatment. TheraBreath developed from a specialist solution for halitosis into a broader consumer brand sold through retail and other distribution channels. In the United Kingdom, the business and product presence has been associated with the name The Breath Co. The brand’s core differentiation is its focus on persistent or clinically framed bad-breath concerns, rather than positioning itself solely as a conventional cosmetic mouthwash. In December 2021, Church & Dwight announced the acquisition of TheraBreath for a reported purchase price of approximately $580 million. The transaction placed the brand within the portfolio of a large publicly traded consumer-products company whose categories include household, personal-care, and specialty products. Under Church & Dwight ownership, TheraBreath remained an active oral-care brand and gained the potential to use the parent company’s distribution, marketing, and commercial infrastructure. Publicly available reference material provides limited detail on the company’s later product launches, executive structure, advertising campaigns, and financial performance. The brand is therefore best understood from the available record as a dentist-founded, halitosis-focused oral-care business that expanded into a broader retail product line before becoming part of Church & Dwight.

TheraBreath originated from dentist Harold Katz’s efforts to understand and address persistent bad breath. In the early 1990s, Katz began researching halitosis after conventional treatment did not solve the problem experienced by his daughter. His work led to the creation of a dedicated oral-care approach aimed at the causes of odor rather than merely covering it with flavoring. Katz formed TheraBreath in 1994. The brand’s products became associated with chlorine dioxide, which was used in formulations intended to help reduce compounds linked to oral malodor. The product concept also addressed areas that can contribute to unpleasant breath, including the tongue, throat, gum tissue, and tonsils. This gave TheraBreath a more treatment-oriented identity than ordinary breath mints or cosmetic mouthwashes. Over time, TheraBreath expanded from its initial bad-breath focus into a broader oral-care range. Its principal consumer formats included oral rinses and other products designed to support breath freshness and oral hygiene. The brand’s dentist founder and its emphasis on halitosis research remained central to its market identity. In the United Kingdom, it has been known as The Breath Co. A major ownership change occurred in December 2021, when Church & Dwight acquired the business. Public references report a purchase price of about $580 million. The transaction made TheraBreath part of Church & Dwight’s consumer-products portfolio and connected the brand to the parent company’s larger sales, distribution, and marketing capabilities. The available reference material does not provide a detailed chronology of individual product introductions, advertising campaigns, leadership changes, or operating results. Accordingly, the documented history is strongest on the brand’s founding purpose, its halitosis-centered product technology, its geographic naming in the United Kingdom, and its 2021 acquisition by Church & Dwight.

1. 2021Acquisition by Church & Dwight

   Church & Dwight acquired TheraBreath in December 2021 in a transaction reported at approximately $580 million.

   Source
2. 1994TheraBreath is established

   Dentist Harold Katz formed TheraBreath after researching persistent bad breath and developing products intended to address halitosis.

   Source

Dentist-founded oral care focused on persistent bad breath and related oral malodor concerns, with a science- and treatment-oriented alternative to purely cosmetic breath freshening.

• TheraBreath oral rinsesMouthwash and oral rinse

  TheraBreath’s oral rinses are the brand’s core product format and are associated with its focus on persistent bad breath. The formulations are linked with chlorine dioxide and are positioned to help address odor-producing compounds in the mouth. The brand’s broader claims and intended use encompass concerns involving the tongue, throat, gum tissue, and tonsils, distinguishing the line from mouthwashes marketed only for short-term flavor freshness.

• TheraBreath toothpasteToothpaste

  TheraBreath toothpaste extends the brand’s bad-breath-focused proposition into routine brushing. It is part of the broader oral-care portfolio associated with dentist-led treatment of oral malodor and daily mouth hygiene. Detailed launch dates and the complete historical formulation range are not specified in the available reference material.

• TheraBreath breath-care productsBreath fresheners and related oral care

  The brand has also been associated with additional breath-care formats, including sprays, lozenges, and related oral products. These formats support the same central promise of managing unpleasant breath and maintaining freshness between routine oral-care occasions. Specific product histories are not documented in the supplied sources.

• 2021Church & Dwight purchases TheraBreathM&A

  TheraBreath had developed from a dentist-founded halitosis solution into a consumer oral-care brand with retail distribution. Church & Dwight acquired the business to add the brand to its consumer-products portfolio.

  What changed. Church & Dwight completed the acquisition in December 2021. Public reference material reports a transaction value of approximately $580 million.

  Aftermath. TheraBreath became part of Church & Dwight’s brand portfolio and remained an active oral-care brand. Detailed post-acquisition operating results and organizational changes are not specified in the available sources.

  Reported acquisition price. $580 million (December 2021)

  Source

• 2021Church & Dwight acquires TheraBreath

  Church & Dwight acquired the TheraBreath oral-care brand in December 2021. The reported transaction value was approximately $580 million.

  M&A
  Source

1. TheraBreath